Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Plant Communications|February 1, 2024
Two aquaporins, PIP1;1 and PIP2;1, mediate the uptake of neonicotinoid pesticides in plantsQun Wan, Yixin Li, Jinjin Cheng, et al.
Blood|March 16, 2025
Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in ChinaDe Zhou, Xianbo Huang, Lixia Zhu, et al.
Frontiers in Psychiatry|March 5, 2025
Association of prenatal trajectories of depressive and anxiety symptoms with neurodevelopment of children aged 0-24 months: A prospective studyRuoqing Chen, Weiying Liu, Feng Wu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 studyLiangshun You, Yi Liu, Wenyuan Mai, et al.
Frontiers in Oncology|September 9, 2020
CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the BrainTongjuan Li, Lei Zhao, Yuanyuan Zhang, et al.
BMC Musculoskeletal Disorders|July 4, 2025
Shear wave elastography of the supraspinatus tendon with early degeneration in asymptomatic type II diabetes mellitus patients: a multicenter studyTong Wang, Yanni He, Wenhong Yi, et al.
Cancer Science|December 6, 2019
Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromesLingxu Jiang, Yingwan Luo, Shuanghong Zhu, et al.
Journal of Cancer Research and Clinical Oncology|March 18, 2018
Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromesPeipei Lin, Yingwan Luo, Shuanghong Zhu, et al.
Cancer Medicine|February 20, 2021
Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromesXuefen Yan, Lu Wang, Lingxu Jiang, et al.
Hematological Oncology|May 30, 2020
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trialXinping Zhou, Chen Mei, Jin Zhang, et al.
Pageof 20